drugset / Trial / NCT03028038

Using Platelet Rich Plasma in Reducing Alveolar Bone Resorption During Rapid Maxillary Expansion

NCT03028038 ↗

Phase 1 Completed 16 enrolled Damascus University
RandomizedCrossoverDouble-blindTreatment

Summary

The purpose of this study is to determine if the injection of Platelet-rich plasma (PRP) is effective in reducing alveolar bone loss that happens after each rapid maxillary expansion (RME) on the buccal aspect of the posterior teeth. 16 patients with a skeletal maxillary constriction aged between 10-16 years old will get into orthodontic treatment to widen the maxilla using Hyrax appliance. An amount of patient blood will be withdrawn and centrifuged to get PRP. Then the PRP will be injected in one half of each patient mouth in a split-mouth design, beneath the buccal periosteal of the first molars and first premolars, the halves will be chosen randomly. High resolution CBCT images will be taken before and after orthodontic treatment to analyze buccal bone thickness and height changes.

Timeline

Start
2016-07
Primary completion
2017-05
Completion
2018-07-15

Outcome

Missed primary endpoint

paper there was no significant difference in BBPT and BBCL between the two groups after RME (P > .05). PMID 30920874 ↗

paper PRP did not minimize alveolar defects after RME. PMID 30920874 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Platelet Rich Plasma Other / unclassified 4 ml Other